Login / Signup

Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72 -associated frontotemporal dementia and amyotrophic lateral sclerosis.

Katherine M WilsonEszter KatonaIdoia GlariaMireia CarcoléImogen J SwiftAitana Sogorb-EsteveCarolin HellerArabella BouziguesAmanda J HeslegraveAshvini KeshavanKathryn KnowlesSaurabh PatilSusovan MohapatraYuanjing LiuJaya GoyalRaquel Sanchez-ValleRobert Jr LaforceMatthis SynofzikJames Benedict RoweElizabeth C FingerRik VandenbergheChristopher R ButlerAlexander GerhardJohn Cornelis van SwietenHarro SeelaarBarbara BorroniDaniela GalimbertiAlexandre de MendonçaMario MasellisM Carmela TartagliaMarkus OttoCaroline GraffSimon DucharmeJonathan M SchottAndrea MalaspinaHenrik ZetterbergRamakrishna BoyanapalliJonathan Daniel RohrerAdrian M Isaacsnull null
Published in: Journal of neurology, neurosurgery, and psychiatry (2022)
repeat-containing transcripts.
Keyphrases
  • amyotrophic lateral sclerosis
  • study protocol
  • phase iii
  • high throughput
  • clinical trial
  • open label